- Home
- CRDF vs KGEI Comparison
CRDF vs KGEI Comparison
Compare CRDF & KGEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- KGEI
- Stock Information
- Founded
- CRDF 1999
- KGEI 2008
- Country
- CRDF United States
- KGEI United States
- Employees
- CRDF N/A
- KGEI N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- KGEI
- Sector
- CRDF Health Care
- KGEI
- Exchange
- CRDF Nasdaq
- KGEI Nasdaq
- Market Cap
- CRDF 233.5M
- KGEI 254.9M
- IPO Year
- CRDF N/A
- KGEI N/A
- Fundamental
- Price
- CRDF $4.04
- KGEI $6.03
- Analyst Decision
- CRDF Strong Buy
- KGEI Strong Buy
- Analyst Count
- CRDF 6
- KGEI 1
- Target Price
- CRDF $11.92
- KGEI $11.00
- AVG Volume (30 Days)
- CRDF 1.4M
- KGEI 491.2K
- Earning Date
- CRDF 08-07-2025
- KGEI 08-12-2025
- Dividend Yield
- CRDF N/A
- KGEI N/A
- EPS Growth
- CRDF N/A
- KGEI 42.32
- EPS
- CRDF N/A
- KGEI 0.57
- Revenue
- CRDF $587,000.00
- KGEI $60,739,000.00
- Revenue This Year
- CRDF N/A
- KGEI $32.19
- Revenue Next Year
- CRDF N/A
- KGEI $33.24
- P/E Ratio
- CRDF N/A
- KGEI $10.57
- Revenue Growth
- CRDF N/A
- KGEI 20.06
- 52 Week Low
- CRDF $2.01
- KGEI $2.85
- 52 Week High
- CRDF $5.64
- KGEI $9.89
- Technical
- Relative Strength Index (RSI)
- CRDF 65.93
- KGEI 41.08
- Support Level
- CRDF $3.07
- KGEI $6.06
- Resistance Level
- CRDF $4.22
- KGEI $8.27
- Average True Range (ATR)
- CRDF 0.22
- KGEI 0.51
- MACD
- CRDF 0.08
- KGEI -0.11
- Stochastic Oscillator
- CRDF 87.35
- KGEI 17.36
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About KGEI Kolibri Global Energy Inc. Common stock
Kolibri Global Energy Inc is a North American energy company focused on finding and exploiting energy projects in oil, gas, and clean and sustainable energy. It is focused on the acquisition, exploration, and production of oil and gas reserves. The company owns and operates shale oil and gas properties in the United States. The company derives a majority of its revenue from the United States.